With almost two years under its belt, the RBDCOV project, dedicated to the development of HIPRA’s BIMERVAX® vaccine against COVID-19 and financed by the European Union under the Horizon Europe programme, explores new dissemination channels through the production of its own podcast: ‘RBDCOV Talks’.
This initiative consists of a series of ten podcast episodes with the participation of clinical research teams, medicine professionals and community advocates in order to facilitate access to technical knowledge for non-specialist groups. At the same time, RBDCOV Talks’ informs the community about the current progress and results of ongoing clinical trials testing the efficacy, tolerability and safety of HIPRA’s recombinant BIMERVAX® vaccine.
Do not miss Asphalion’s expert Helena Belinchón on episode 2 “What’s Drug Safety? What is Drug Safety-level monitoring like in vaccine clinical trials?” and discover the critical role of Drug Safety in vaccine clinical trials.
You can contact us for further information at: email@example.com